US Starts Clinical Trial for mRNA Nipah Virus Vaccine
The experimental Nipah virus vaccine (mRNA-1215) is manufactured by Moderna, Inc. and was developed in collaboration with NIAID’s Vaccine Research ...
Tag: NIH
US Begins Phase 1 Clinical Trial of Universal Flu Vaccine
A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes ...
Nanoparticle Mosaic Quadrivalent Flu Vaccine Phase 1 Clinical Trial Gets Underway
NIH Launches Clinical Trial of Universal Influenza Vaccine Candidate A first-in-human, Phase 1 trial assessing the safety and immunogenicity of ...
Lilly Begins Clinical Testing of Therapies for COVID-19
Eli Lilly announced it has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part ...
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding
The National Institutes of Health (NIH) has selected Soligenix's SGX942 (dusquetide) for the treatment of oral mucositis in head and ...
NIH Clinical Center Seeks Decontamination Services for Drug-Resistant Bacteria
The National Institutes of Health (NIH) Clinical Center Hospital Epidemiology Service (HES) is seeking vendor quotes for decontamination services of ...
NIAID Virology Quality Assurance Program
The National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS (DAIDS) is seeking proposals from qualified offerors to ...
Fogarty International Center Advisory Board Meets 7 Feb
The National Institutes of Health (NIH) Fogarty International Center Advisory Board will host a meeting on February 7, 2017 in ...
RFI – National Gene Vector Biorepository and Coordinating Center
A Request for Information (RFI) from the National Institutes of Health (NIH) seeks responses from small businesses regarding their ability ...
NIH Awards 19M for Development of Nerve Agent Medical Countermeasures
The National Institutes of Health (NIH) has awarded Rutgers University a five-year grant for more than $19 million for research ...
RFI – Supporting Development of Therapeutics for Rare and Neglected Diseases
The National Center for Advancing Translational Sciences (NCATS) is conducting market research to determine capabilities of existing organizations that execute ...
NIH Seeks Modular Trailer for Manufacturing Critical Retroviral Vectors
The NIH Clinical Center in Bethesda, Md. Credit: NIH The recent shutdown of the National Institutes of Health (NIH) Clinical ...
NHLBI Updates Research Topics of Special Interest
The National Heart, Lung, and Blood Institute (NHLBI) this week provided an update to its research topics of special interest ...
PREVAIL IV Trials Treatment for Persistent Ebola in Semen
The Partnership for Research on Ebola Virus in Liberia (PREVAIL), a U.S.-Liberia joint Clinical Research Partnership, announced on July 5 ...
NIH Funds U.S. Olympic Team Zika Monitoring Study
Researchers supported by the National Institutes of Health (NIH) will monitor potential Zika virus exposure among a subset of athletes, ...
Researchers Discover 2009 Swine Flu Pandemic Originated in Mexico
The 2009 swine H1N1 flu pandemic -- responsible for more than 17,000 deaths worldwide -- originated in pigs from a ...
UTHealth Awarded 11M to Study Deadly Prions
UTHealth's Claudio Soto, Ph.D., has received an $11 million NIH grant to study prion diseases. Researchers from McGovern Medical School ...
Gain-of-Function Research Symposium Summary
Research involving pathogens provides insight into the fundamental nature of human-pathogen interactions, enables the assessment of the pandemic potential of ...
Zika’s Potential Threat to World Blood Supply
Blood safety researchers say it is highly likely that the mosquito-borne Zika virus can be transmitted through blood transfusions and ...
Infectious Disease Safety Training Program for First Responders
Credit: Cleopatra Adedeji/CDC The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, is launching ...
